Betta pharmaceuticals agrees to obtain commercialization rights for agenus' drugs

Says it agrees to obtain commercialization rights for agenus' <<>> balstilimab and zalifrelimab in mainland china, hong kong, macau and taiwan.says the rights exclude drug use via intravesical administration.says its hong kong unit agrees to buy 4.96 million shares in agenus for $20 million.

AGEN Ratings Summary

AGEN Quant Ranking